Skip to Content

Pfizer/BioNTech COVID-19 Vaccine Highly Effective Six Months After Second Dose

THURSDAY, April 1, 2021 -- The Pfizer/BioNTech COVID-19 vaccine is more than 91 percent effective six months after people get their second dose, according to new test data released by the companies.

The findings from more than 46,000 trial participants was released Thursday, CBS News reported. There were 927 confirmed symptomatic cases of COVID-19 overall, with 850 cases in the placebo group and 77 cases among those who received the vaccine.

The companies also announced that the vaccine is safe and effective in children as young as 12 years, and they plan to seek emergency use authorization in the United States and Europe for the vaccine to be given starting at age 12 years, CBS News reported.

That means that children 12 years and older could start receiving the vaccine before going back to school in the fall.

CBS News Article

© 2021 HealthDay. All rights reserved.

Read this next

Global COVID-19 Death Toll Surpasses 3 Million

MONDAY, April 19, 2021 -- The official global COVID-19 death toll surpassed 3 million this weekend, according to Johns Hopkins University data. But the actual number of people...

Third Booster COVID-19 Vaccine Shot Available by Fall: Moderna

MONDAY, April 19, 2021 -- Moderna says a third booster shot for its two-dose COVID-19 vaccine will be available in the United States by the fall. The announcement was made by...

Oregonians Rebel as State Considers 'Indefinite Extension' of Pandemic Rules

MONDAY, April 19, 2021 -- An indefinite extension on wearing masks and social distancing in all businesses is being considered by the administrator of the Oregon Department of...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.